Alan Palmer,
CSO
Alan has formed or co-founded six biotech start-up companies. He is presently a Board director of Cerebroscience, MS Therapeutics Ltd, One Nucleus, Neuro 360 and the British Neuroscience Association. With over 100 peer-reviewed papers to his name, his scientific research has had a high impact, particularly in the study of dementia and traumatic brain injury. Alan is visiting Professor at University College London and the University of Reading and Life Science Entrepreneur in Residence at the University of Bristol. He was voted London Biotechnology Network Entrepreneur of the Year in 2005.
|
|
|
